The Role of the Kidney in Cardiovascular Disease Educational Tools Contest, Sponsored by the American Heart Association KCVD, Returns

Full access

The American Heart Association (AHA) Council on the Kidney in Cardiovascular Disease (KCVD) is continuing a contest to promote educational tools spanning heart disease and kidney diseases. The role of the kidney in cardiovascular disease (CVD) is widely recognized among nephrologists, but there is scant education about this among primary care practitioners, during medical school, and during residency training. Novel therapies continue to be developed (e.g., sodium glucose co-transporter 2 [SGLT2] inhibitors, for example), and it is imperative to develop new teaching tools that are far reaching in scope and scale.

The Role of the Kidney in Cardiovascular Disease Educational Tools Contest supports the creation of an educational tool aimed at educating physicians/clinicians, trainees, and students about the impact of chronic kidney disease on CVD. The following are contest requirements:

  • The teaching tool must enhance the learner's understanding of kidney diseases and CVD to impact clinical decision-making or awareness. The tool can be a video series, interactive website, or a podcast.

  • It must teach some aspect about the connection between the kidney and CVD through clinical studies, basic science, translational research, etc.

  • One member of the submitting team must be an AHA member. Teams can consist of undergraduate, medical, or PhD students; trainees (resident, fellow, and post-doc); faculty; practicing physicians; researchers; or other health professionals, but one member must have a faculty position in either private practice or at an academic institution. Each member of the team can only be involved in one submission. A corresponding member must be denoted.

Applications are due July 28, 2023. Please see for more information.

The teaching tool will be submitted and judged based on the following merits:

  • Kidney and CVD must be featured.

  • The tool must be easily accessible.

  • The tool must have feasibility for creation (meaning it can be developed).

  • A prototype of the tool should be submitted (does not have to be the final product).

Up to three teaching tools will be selected as winners with the following results:

  • Each team will receive up to $2000 for further development of the tool.

  • AHA's KCVD will publicize the tool.

  • Winners will be announced at AHA Scientific Sessions 2023.

  • The tool will be linked on the AHA website with a description.

  • Each winner will make a video describing the tool.